The importance of Ethical Medical Practices in Managing Non Communicable Disease

Published on: April 28, 2025

Overview

Ethical medical practices are crucial in managing non-communicable diseases (NCDs) such as diabetes, heart disease, and cancer, which require long-term, patient-centered care. Upholding principles like honesty, informed consent, confidentiality, and equitable access helps build trust, improve treatment adherence, and ensure fair and compassionate care. As NCDs continue to rise globally, integrating ethical standards into healthcare delivery and policy is essential for achieving effective and sustainable health outcomes.

Objectives

The objective of this topic is to emphasize the critical role of ethical medical practices in the effective management of non-communicable diseases (NCDs). It aims to highlight how principles such as patient autonomy, informed consent, confidentiality, transparency, and equitable care contribute to building trust, improving treatment adherence, and enhancing patient outcomes. Additionally, the topic seeks to promote awareness among healthcare professionals and policymakers about the need for ethical decision-making in long-term care, reducing health disparities, and ensuring that patients with chronic conditions receive respectful, fair, and compassionate treatment throughout their healthcare journey.

Number of participants

63 students from M.Sc Yoga Sciences and B.Sc Yoga Science and Holistic Health attended this session.

Outcomes

Ethical medical practices in managing non-communicable diseases lead to improved patient trust, better treatment adherence, equitable access to care, enhanced quality and safety of care, and long-term positive health outcomes. They also uphold professional integrity and reduce health disparities.

Picture1-10
Picture2-10
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.